Target intelligence / Profile preview

Cyclin D3 pseudogene 2 (CCND3P2)

Target
CCND3P2
Molecular classification
Other
01

Overview

Cyclin D3 pseudogene 2 (CCND3P2) is a human pseudogene—it is a non-coding genetic element similar in sequence to the functional cyclin D3 (CCND3) gene but does not encode a functional protein. Pseudogenes are remnants of genes that have lost their protein-coding ability or are no longer expressed in the cell. As such, CCND3P2 does not have a recognized role as a therapeutic target, does not encode a protein with biological function, and is not associated with disease mechanisms, drug interactions, or biomarker status[2]. Misidentification or confusion may occur between CCND3P2 and the functional CCND3 gene, which encodes the G1/S-specific cyclin-D3, a cell cycle regulator[1][6].\n\nKey clarification:\nCCND3P2 is not a protein, not a receptor, not a functional gene product, and has no established role in disease or therapy. If the intent is to target cyclin D3 itself, then "Cyclin D3" (CCND3) should be used instead. CCND3P2 should not be used as a therapeutic target or biomarker name[2].

Other names
Cyclin D3 Pseudogene 2CCND3P2

Beyond the preview

Go deeper on Cyclin D3 pseudogene 2 (CCND3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin D3 pseudogene 2 (CCND3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call